Abstract Accurate prediction of pathologic response to neoadjuvant chemo-immunotherapy for NSCLC at baseline is important for personalized perioperative treatment selection. However, as a new therapy, there is a lack of sufficient clinical cohorts for model development. Our study aims to develop and validate an AI-expert collaboration generative integration system (AEGIS) to predict the pathologic response to neoadjuvant chemo-immunotherapy for NSCLC using baseline CT.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Weinuo
Contact Weinuo, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack